At the time of writing, Telesis Bio Inc [TBIO] stock is trading at $0.66, down -15.38%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TBIO shares have gain 108.93% over the last week, with a monthly amount glided 94.12%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 26, February 2024, Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results. In a post published today on Yahoo Finance, Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expense.
From an analyst’s perspective:
For the past year, the stock price of Telesis Bio Inc fluctuated between $0.30 and $3.32. Telesis Bio Inc [NASDAQ: TBIO] shares were valued at $0.66 at the most recent close of the market.
Analyzing the TBIO fundamentals
According to Telesis Bio Inc [NASDAQ:TBIO], the company’s sales were 30.00M for trailing twelve months, which represents an -16.64% plunge. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5870 points at the first support level, and at 0.5140 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7460, and for the 2nd resistance point, it is at 0.8320.
Telesis Bio Inc [TBIO] reported earnings per share of -$0.37 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.3/share, meaning a difference of -$0.07 and a surprise factor of -23.30%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.28 per share as compared to estimates of -$0.32 per share, a difference of $0.04 representing a surprise of 12.50%.
Ratios To Look Out For
It is important to note that Telesis Bio Inc [NASDAQ:TBIO] has a current ratio of 2.07. As well, the Quick Ratio is 1.91, while the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 0.66, the price to book ratio is 1.11.
Transactions by insiders
Recent insider trading involved Nelson Todd Robert, President & CEO, that happened on May 04 when 2575.0 shares were sold. Chief Technology Officer, Gibson Daniel Glenn completed a deal on May 04 to sell 1190.0 shares. Meanwhile, Chief Legal Officer Cutler Rob sold 1174.0 shares on May 04.
